Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo

European Journal of Pharmacology

Volumn 418, Issue 3, 2001, Pages 207-211

  Acquas, Elio ^a   Marrocu, Paola ^a   Pisanu, Augusta ^a   Cadoni, Cristina ^b   Zernig, Gerald ^c   Saria, Alois ^c   Di Chiara, Gaetano ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CNR   (Italy)

^c Department of Psychiatry   (Austria)

Author keywords

( ) 3,4 Methylendioxymethamphetamine (MDMA, ecstasy); Acetylcholine; Microdialysis; Prefrontal cortex; Striatum

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLCHOLINE;

ACETYLCHOLINE RELEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DOSE TIME EFFECT RELATION; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RAT; STIMULATION;

ACETYLCHOLINE; ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0035957734     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00937-2     Document Type: Article

References (22)

1. Acquas E., Di Chiara G. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine. Eur. J. Pharmacol. 383(2):1999;121-127.
2. 1-receptor mediated increases in acetylcholine release in rat frontal cortex. Psychopharmacology. 125:1996;162-167.
3. Acquas E., Fibiger H.C. Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition. J. Neurochem. 70:1998;1088-1093.
4. Acquas E., Wilson C., Fibiger H.C. Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear. J. Neurosci. 16:1996;3089-3096.
5. Consolo S., Girotti P., Russi G., Di Chiara G. Endogenous dopamine facilitates striatal in vivo acetylcholine release by acting on D1 receptors localized in the striatum. J. Neurochem. 59:1992;1555-1557.
6. Crane A.M., Porrino L.J. Adaptation of the quantitative 2-[14C]deoxyglucose method for use in freely moving rats. Brain Res. 499:1989;87-92.
7. Damsma G., Westerink B.H., de Vries J.B., Van den Berg C.J., Horn A.S. Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis. J. Neurochem. 48:1987;1523-1528.
8. Damsma G., Robertson G.S., Tham C.S., Fibiger H.C. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 259:1991;1064-1072.
9. Day J., Fibiger H.C. Dopaminergic regulation of cortical acetylcholine release. Synapse. 12:1992;281-286.
10. Day J., Damsma G., Fibiger H.C. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study. Pharmacol., Biochem. Behav. 38:1991;723-729.
11. Downing J. The psychological and physiological effects of MDMA on normal volunteers. J. Psychoact. Drugs. 18:1986;335-340.
12. Fischer H.S., Zernig G., Schatz D.S., Humpel C., Saria A. MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum. Eur. J. Neurosci. 12:2000;1385-1390.
13. Green A.R., Cross A.J., Goodwin G.M. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology (Berlin). 119:1995;247-260.
14. Hiramatsu M., Cho A.K. Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study. Neuropharmacology. 29:1990;269-275.
15. Hirano H., Day J., Fibiger H.C. Serotonergic regulation of acetylcholine release in rat frontal cortex. J. Neurochem. 65:1995;1139-1145.
16. Imperato A., Obinu M.C., Gessa G.L. Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. Eur. J. Pharmacol. 238:1993;377-381.
17. Mizuno T., Endo Y., Arita J., Kimura F. Acetylcholine release in the rat hippocampus as measured by the microdialysis method correlates with motor activity and exhibits a diurnal variation. Neuroscience. 44:1991;607-612.
18. Moore H., Sarter M., Bruno J.P. Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands. Brain Res. 627:1993;267-274.
19. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 4th edn. 1998;Academic Press, Sydney.
20. Ratzenboeck E., Saria A., Kriechbaum N., Zernig G. Reinforcing effect of 3,4-methylendioxymethamphetamine (MDMA, "ecstasy") in naive and cocaine-trained rats. Pharmacology. 62(3):2001;138-144.
21. Rudnick G., Wall S.C. The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. U. S. A. 89:1992;1817-1821.
22. Schmidt C.J., Levin J.A., Lovenberg W. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol. 36:1987;747-755.